Exkivityt (mobocertinib) Capsules

A kinase inhibitor called EXKIVITY is prescribed for adult patients whose disease has progressed during or following platinum-based chemotherapy and who have locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations, as determined by an FDA-approved test.

Recommended Dosage:

160 mg taken once daily, with or without food, is the recommended dosage. 

Warnings and Precautions:

Lung and Breathing Problems:

Keep an eye on any new or worsening breathing problems while taking Exkivity. If you have signs like trouble breathing or coughing, tell your doctor right away. They might stop Exkivity if they suspect a lung problem.

Heart Health:

Your heart's health will be checked before and during Exkivity treatment. If there are concerns about how your heart is working, the dosage might change or the medication might be stopped.

Dealing with Diarrhea:

Diarrhea might happen while you're on Exkivity. It could lead to dehydration or issues with your body's balance of minerals. Your doctor might suggest medicine for diarrhea and ask you to drink more fluids. They could adjust the Exkivity dose if it becomes severe.

Pregnancy Precautions:

If you can get pregnant, be aware that Exkivity might harm an unborn baby. It's important to use effective non-hormonal birth control while taking Exkivity to prevent pregnancy.

Documentation & Availability in India:

If you are considering the import of Exkivity (Mobecertinib succinate)  to India, please be aware that Exkivity can be imported by patients or government hospitals solely in the name of the patients. The following documentation is essential for the successful import of this medication:

Required Documentation for Import:

• A valid prescription from a qualified medical practitioner.
• Diagnostic reports of the patient.
• Government-issued identification proof for the patient, as recognized by the Government of India.

Order Confirmation Process: 

The order for Exkivity will be confirmed upon the receipt of the following documents:

• A valid prescription from a qualified doctor.
• An import permit, if applicable.

Availability of Exkivity in India: 

Exkivity (Mobecertinib succinate)  is classified as a prescription pharmaceutical drug. Consequently, it legally requires a medical prescription to be dispensed. Indian Pharma Network (IPN) specializes in facilitating the import of cancer medicines through named patient supply (NPS), ensuring transparency and authenticity by sourcing from reputable suppliers in the USA, Canada, Europe, and Australia.

Exkivity can be made accessible to patients, doctors, and hospitals in various cities across India, including but not limited to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune. To confirm an order, a valid prescription from a doctor and an import permit will be required.

IPN (Indian Pharma Network) is dedicated to facilitating the supply of Exkivity (prescription medicines) to locations both within India and worldwide, while adhering to relevant legal requirements.

For inquiries regarding the price of Exkivity in India and to initiate the ordering process, please reach out to us through the following contact details:

Our commitment lies in assuring quality and timely delivery to meet the healthcare needs of patients and medical professionals across the globe.

Sourcing & Delivery: Indian Pharma Network is proficient in sourcingExkivity (Mobecertinib succinate)  from around the world and ensuring efficient delivery to patients. We provide worldwide access to the best available treatments and expedite prescription dispensing and delivery, with all prescriptions being dispensed and scrutinized by registered pharmacists before dispatching them to the patient's address, exclusively from New Delhi, India.

FAQ’s

What is Exkivity (Mobocertinib succinate)?

Exkivity, also known as Mobocertinib succinate, is an oral medication used for the treatment of non-small cell lung cancer (NSCLC). Specifically, it targets tumors with certain mutations in the epidermal growth factor receptor (EGFR) gene, such as exon 20 insertion mutations, which are typically resistant to other EGFR inhibitors.

How does Exkivity work?

Exkivity is a tyrosine kinase inhibitor (TKI) that works by blocking the activity of mutated EGFR proteins in cancer cells. EGFR mutations, especially exon 20 insertions, can drive the growth of cancer cells. Exkivity inhibits the abnormal signaling caused by these mutations, thereby slowing down or halting the growth of cancer cells.

What are the common side effects of Exkivity?

Common side effects of Exkivity may include diarrhea, rash, nausea, vomiting, fatigue, decreased appetite, mouth sores, and abdominal pain. Additionally, Exkivity can cause more serious side effects such as interstitial lung disease/pneumonitis, liver problems, and heart problems.

How is Exkivity taken?

Exkivity is taken orally in the form of tablets. The typical recommended dosage is usually once daily with or without food. Dosage and administration may vary based on individual patient factors and should be taken as directed by a healthcare professional.

Who is a candidate for Exkivity treatment?

Exkivity is approved for adult patients with NSCLC that have specific EGFR mutations, particularly exon 20 insertion mutations, and have progressed after previous treatment or are unable to tolerate other EGFR inhibitors. Patients should undergo genetic testing to confirm the presence of these mutations before starting treatment with Exkivity.